{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:22:17Z","timestamp":1787570537311,"version":"build-2736575974"},"reference-count":21,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T00:00:00Z","timestamp":1787443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Dev. Dis.","JCDD"],"abstract":"<jats:p>(1) Introduction: Early identification of patients at high risk of recurrent events after hospitalization for acute decompensated heart failure (ADHF) remains challenging. The Larissa Heart Failure Risk Score (LHFRS) is a simple prognostic tool based on hypertension, coronary artery disease, and red blood cell distribution width. Urinary sodium has recently emerged as an objective marker of natriuretic response and decongestion. We prospectively evaluated whether incorporation of urinary sodium improves the prognostic performance of the LHFRS. (2) Methods: This prospective single-center observational study enrolled 130 consecutive adults hospitalized with ADHF. Clinical, laboratory, electrocardiographic, and echocardiographic data were collected at admission. Spot urinary sodium and chloride were measured at admission and 2 h after intravenous loop diuretic administration according to a standardized decongestion protocol. The primary endpoint was heart failure rehospitalization within 3 months. Secondary endpoints included all-cause mortality and the composite of death or heart failure rehospitalization. Multivariable logistic regression with bootstrap internal validation (1000 resamples) was used to identify independent predictors of outcomes. (3) Results: The study population included patients across the spectrum of heart failure phenotypes (HFrEF 58%, HFmrEF 7%, HFpEF 35%). During follow-up, 48 patients (36.9%) experienced heart failure rehospitalization and 23 (17.7%) died. The LHFRS independently predicted 3-month rehospitalization (B = 0.490, p = 0.041). Admission urinary sodium and 2-h urinary sodium provided incremental prognostic information beyond the LHFRS and remained independently associated with rehospitalization after multivariable adjustment (p = 0.008 and p = 0.001, respectively). Urinary chloride demonstrated similar prognostic associations, whereas conventional renal biomarkers, including serum creatinine, urea, estimated glomerular filtration rate, serum sodium, and NT-proBNP, did not consistently retain independent prognostic significance. The LHFRS was also significantly associated with the composite endpoint of death or rehospitalization (B = 1.173, p = 0.002), while its association with mortality alone was not statistically significant (B = \u22125.551, p = 0.256). (4) Conclusions: Lower admission and 2-h urinary sodium concentrations were associated with 3-month HF rehospitalization after adjustment for the LHFRS. These findings are hypothesis-generating and require confirmation in larger, externally validated multicenter cohorts.<\/jats:p>","DOI":"10.3390\/jcdd13090405","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:07:53Z","timestamp":1787566073000},"page":"405","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating Urinary Sodium into the Larissa Heart Failure Risk Score Improves Early Risk Stratification in Acute Heart Failure"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8331-9825","authenticated-orcid":false,"given":"Nikolaos","family":"Chrysakis","sequence":"first","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5417-6392","authenticated-orcid":false,"given":"Dimitrios E.","family":"Magouliotis","sequence":"additional","affiliation":[{"name":"Department of Cardiac Surgery Research, Lankenau Institute for Medical Research, Wynnewood, PA 19096, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Leventis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Katsimperi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grigorios","family":"Giamouzis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4016","authenticated-orcid":false,"given":"Filippos","family":"Triposkiadis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"},{"name":"School of Medicine, European University Cyprus, P.O. Box 22006, Nicosia 2404, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-2478","authenticated-orcid":false,"given":"John","family":"Skoularigis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Xanthopoulos","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece"},{"name":"School of Medicine, European University Cyprus, P.O. Box 22006, Nicosia 2404, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Bohm, M., Burri, H., Butler, J., and Celutkiene, J. (2023). 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. Heart J., 44, 3627\u20133639.","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force Members, McDonagh, T.A., Metra, M., Adamo, M., Gardner, R.S., Baumbach, A., Bohm, M., Burri, H., Butler, J., and Celutkiene, J. (2022). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail., 24, 4\u2013131.","DOI":"10.1002\/ejhf.2333"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ejhf.1132","article-title":"Larissa Heart Failure Risk Score: A proposed simple score for risk stratification in chronic heart failure","volume":"20","author":"Xanthopoulos","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/ejhf.1546","article-title":"In-hospital red blood cell distribution width change in patients with heart failure","volume":"21","author":"Xanthopoulos","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Xanthopoulos, A., Skoularigis, J., Briasoulis, A., Magouliotis, D.E., Zajichek, A., Milinovich, A., Kattan, M.W., Triposkiadis, F., and Starling, R.C. (2023). Analysis of the Larissa Heart Failure Risk Score: Predictive Value in 9207 Patients Hospitalized for Heart Failure from a Single Center. J. Pers. Med., 13.","DOI":"10.3390\/jpm13121721"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijcard.2019.12.051","article-title":"Validation of the Larissa Heart Failure Risk Score for risk stratification in acute heart failure","volume":"307","author":"Kitai","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1038\/s41569-025-01152-z","article-title":"Decongestion in heart failure: Medical and device therapies","volume":"22","author":"Cox","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41569-020-0379-7","article-title":"Congestion in heart failure: A contemporary look at physiology, diagnosis and treatment","volume":"17","author":"Boorsma","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0300-8932(10)70002-6","article-title":"The active role of venous congestion in the pathophysiology of acute decompensated heart failure","volume":"63","author":"Colombo","year":"2010","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41591-023-02532-z","article-title":"Natriuresis-guided diuretic therapy in acute heart failure: A pragmatic randomized trial","volume":"29","author":"Beldhuis","year":"2023","journal-title":"Nat. Med."},{"key":"ref_11","first-page":"101509","article-title":"The role of urine sodium in acutely decompensated heart failure","volume":"55","author":"Hoen","year":"2024","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5005\/jp-journals-10071-23328","article-title":"Red Cell Distribution Width as a Novel Prognostic Marker in Multiple Clinical Studies","volume":"24","author":"Yousefi","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.acvd.2014.10.002","article-title":"Prognostic markers of acute decompensated heart failure: The emerging roles of cardiac biomarkers and prognostic scores","volume":"108","author":"Laribi","year":"2015","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jacc.2008.08.072","article-title":"Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment","volume":"53","author":"Flaherty","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","first-page":"e011105","article-title":"Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study","volume":"17","author":"Dauw","year":"2024","journal-title":"Circ. Heart Fail."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/ejhf.1428","article-title":"Serial assessment of spot urine sodium predicts effectiveness of decongestion and outcome in patients with acute heart failure","volume":"21","author":"Biegus","year":"2019","journal-title":"Eur. J. Heart Fail."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jjcc.2025.06.018","article-title":"Diuretic resistance measured by sodium excretion and urine output in acute heart failure: The DIURESIS-AHF study","volume":"87","author":"Fujimoto","year":"2026","journal-title":"J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/clc.23286","article-title":"Lower urine sodium predicts longer length of stay in acute heart failure patients: Insights from the ROSE AHF trial","volume":"43","author":"Cunningham","year":"2020","journal-title":"Clin. Cardiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cardfail.2024.08.044","article-title":"Rationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study","volume":"31","author":"Vanhentenrijk","year":"2025","journal-title":"J. Card. Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"Valente","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Triposkiadis, F., and Brutsaert, D.L. (2025). Evidence-Based Medicine: Past, Present, Future. J. Clin. Med., 14.","DOI":"10.20944\/preprints202506.1732.v1"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/405\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:38:52Z","timestamp":1787567932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/13\/9\/405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,23]]},"references-count":21,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcdd13090405"],"URL":"https:\/\/doi.org\/10.3390\/jcdd13090405","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,23]]}}}